ATLASMoleculin Biotech (MBRX) earnings date: Nov 12, 2026
Moleculin Biotech (MBRX) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026. Analysts expect EPS of -$9.90.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on MBRX
| Last price | $8.15 (+3.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±9.7% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Moleculin Biotech stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Moleculin Biotech reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Moleculin Biotech. You can switch it off at any time.
Alert me before MBRX reportsFree to start. Creating an account takes under a minute.
Notify me when Moleculin Biotech reports
Track MBRX free Add Moleculin Biotech to a free ATLAS watchlist and see its next report date in one place.
MBRX earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$9.90 |
| Last report | Aug 13, 2026 · Beat |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | -56.1% |
| Average move around a report | ±15.3% (last 5) |
| Sector | Healthcare · Biotechnology |
Moleculin Biotech earnings history: last 5 reports
Moleculin Biotech last reported on Aug 13, 2026: EPS of -$28.00 against an estimate of -$31.07 (+9.9% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$31.07 | -$28.00 | +9.9% | Beat | +17.2% |
| Jul 28, 2026 | $0.87 | $0.89 | +2.3% | Beat | -37.9% |
| May 14, 2026 | -$33.27 | -$70.80 | -112.8% | Miss | -1.9% |
| Nov 13, 2025 | -$131.67 | -$340.00 | -158.2% | Miss | -11.0% |
| Aug 12, 2025 | -$201.67 | -$245.00 | -21.5% | Miss | +8.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for MBRX
See the fair value, the probability range and the earnings history of Moleculin Biotech on its ATLAS page.
Moleculin Biotech (MBRX) stock analysisPlans from €3.99 a month.
Moleculin Biotech earnings: frequently asked questions
When does Moleculin Biotech (MBRX) report earnings?
Moleculin Biotech is scheduled to report on Thursday, November 12, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for MBRX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$9.90 per share (USD). Estimates can change before the report.
How often does MBRX beat earnings estimates?
Of its last 5 reports with a recorded result, Moleculin Biotech beat the EPS estimate 2 times; the average surprise was -56.1%. Past results do not predict the next one.
How much does MBRX move around earnings?
Over its last 5 reports the stock moved an average of 15.3% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Moleculin Biotech beat earnings estimates last quarter?
Moleculin Biotech last reported on Aug 13, 2026: EPS of -$28.00 against an estimate of -$31.07 (+9.9% surprise), a beat.
How much does MBRX usually move in a day?
On a normal trading day the ATLAS model puts MBRX’s one-day range at about ±9.7%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer